Now showing items 6-25 of 1
Bevacizumab (1) |
bevacizumab (1) |
cancer chemotherapy (1) |
cancer combination chemotherapy (1) |
cancer staging (1) |
cetuximab (1) |
cost effectiveness analysis (1) |
cost utility analysis (1) |
Cost-effectiveness analysis (1) |
Cost-utility analysis (1) |
Crizotinib (1) |
crizotinib (1) |
data base (1) |
docetaxel (1) |
drug cost (1) |
drug efficacy (1) |
economic aspect (1) |
Embase (1) |
Erlotinib (1) |
erlotinib (1) |
Now showing items 6-25 of 1